DOCSLIB.ORG

Light Chain Types of Igd in Human Bone Marrow and Serum

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Light Chain Types of Igd in Human Bone Marrow and Serum Clin. exp. Immunol. (1985) 60, 654-660. Light chain types of IgD in human bone marrow and serum J. A. VAN NIEUWKOOP * & J. RADLt *Department ofImmunohaematology and Bloodbank, University Hospital, Leiden and tTNO Institutefor Experimental Gerontology, Rijswyjk, The Netherlands (Acceptedfor publication 24 January 1985) SUMMARY One of the unexplained features of human IgD is its preferential expression with either kappa or lambda light chains in different situations. While the membrane IgD on B lymphocytes shows a predominance of the kappa type, about 90% of all known IgD myeloma proteins and 87% of normal IgD producing plasma cells in spleens of healthy individuals were shown to belong to the lambda type. Very little is known of the kappa/lambda light chain distribution of normal polyclonal IgD in the serum and in the bone marrow plasma cells. In this study, the kappa/lambda representation of IgD in bone marrow plasma cells and in the serum of 25 adult persons (two healthy and 23 suffering from various nonmalignant diseases) was investigated. The kappa/lambda ratio of IgD+ bone marrow plasma cells showed a large variation among the individuals ofthis group, in 84% of the cases being below 1 0. While about 1/3 of the investigated subjects had 80% or more of IgD of the lambda type (kappa/lambda ratio below 0 2), most showed a kappa/lambda ratio of IgD higher than that, with four persons exhibiting a clear cut predominance of IgD of the kappa type. A positive correlation (Spearman's correlation co-efficient, P=0 005) between the percentages of IgD+ plasma cells and their kappa/lambda ratio was found. Semiquantitative evaluation of the kappa/lambda composition within the serum IgD by immunoselection was in agreement with the kappa/lambda ratio of IgD+ plasma cells in all individual cases. Keywords IgD light chain types serum IgD bone marrow IgD INTRODUCTION IgD, a predominant membrane immunoglobulin on B lymphocytes but a very minor component of the serum antibody pool, represents one of the unexplained and controversial issues in immunology. IgD is different from other immunoglobulins in structure, resistance to enzymatic treatment, biological site and behaviour in the immune response; its function as a membrane receptor as well as a secreted protein remains largely obscure. Another strange feature of IgD concerns its preferential expression of either kappa or lambda light chains in different situations. While most membrane IgD was found to be of the kappa type (Rowe et al., 1973; Johnston et al., 1982; Ligthart, Schuit & Hijmans, 1985), about 90% of all known IgD myeloma proteins have been shown to contain lambda light chains (Fine et al., 1974; Jancelewicz et al., 1975; Kyle and Bayrd, 1976; Fibbe & Jansen, 1984). Also, normal IgD producing plasma cells from spleens of healthy individuals showed a definite predominance of lambda light chains (Pernis, Governa & Rowe, 1969). Very little is known ofthe kappa/lambda light chain distribution ofnormal polyclonal IgD in the serum and in the bone marrow plasma cells. Correspondence: Mrs J. A. van Nieuwkoop, Department of Immunohaematology and Bloodbank, University Hospital, Leiden, The Netherlands. 654 IgD types in bone marrow and serum 655 In this investigation, we have demonstrated that most individuals with normal serum IgD levels and normal numbers of IgD positive plasma cells in the bone marrow produce IgD of predominantly lambda type, with, however, large variation. Persons with increased serum levels and increased numbers ofbone marrow plasma cells ofthe IgD isotype often show a shift in the IgD kappa/lambda ratio towards the kappa type. MATERIALS AND METHODS Persons under investigation. Twenty-five adult patients ofthe University Hospital in Leiden were selected for this study because ofthe fact that their bone marrow and serum samples were available and because the bone marrow preparations contained enough IgD positive plasma cells to be investigated (Table 1). Their clinical diagnoses were classified arbitrarily into the following four groups. (1) Hyperimmunoglobulinaemia D and periodic fever syndrome (van der Meer et al., 1984) (three patients). (2) Diseases in which the immune system is presumably not involved, such as diabetes mellitus, von Willebrand's disease, malabsorption syndrome, polyneuropathy and ischaemic heart disease (14 patients). (3) Non-malignant diseases in which the immune system might potentially be involved, such as rheumatoid arthritis and vasculitis (six patients). (4) Healthy persons selected as bone marrow donors for a family member suffering from aplastic anaemia or acute myeloid leukaemia (two persons). Malignancies of the immune system such as multiple myeloma, Waldenstr6m's macroglobulinaemia and non-Hodgkin lymphoma were excluded from this study. Serum samples. All serum samples were processed at less than 1 h after venipuncture; because of the high susceptibility of IgD to degradation during storage by proteolytic enzymes present in the serum (Skvaril & Radl, 1967), 8-aminocaproic acid was added to a final concentration of 0.5% (Skvaril & Griinberger, 1962) before storage at - 20'C. All sera were tested by agar electrophoresis according to Wieme (1965) and by immunoelectrophoresis (IEP) using an oligospecific antiserum to IgG, IgA, IgM and IgD classes and both kappa and lambda light chain types (Nordic Immunological Laboratories). An immunoselection technique (IS) for IgD (Radl, 1970, 1972) was carried out in order to exclude IgD paraproteins and to assess the kappa/lambda light chain representation within the heterogeneous IgD. Quantification of IgD was done by single radial immunodiffusion according to Mancini, Carbonara & Heremans (1965) in Behringwerke Partigen Plates (Hoechst-Behringwerke, Marburg/Lahn, FRG). The IgD levels were expressed in iu/ml and in mg/dl (Rowe, Anderson & Tackett, 1970) and values exceeding 15 mg/dl were considered as increased (Buckley & Fiscus, 1975). If a monoclonal component of any isotype was detected or suspected by employing the above techniques, the serum was also tested by immunofixation (IFIX) in a modification described elsewhere (Radl, 1981). Bone marrow cells. Cytocentrifuge slides were prepared according to Hijmans, Schuit & Klein (1969). These preparations contain comparable numbers of nucleated cells equally distributed over the same area and are therefore, suitable for comparative studies. After fixation for 15 min in 5% acetic acid in ethanol at -20°C and washing, a set of five slides was stained with FITC labelled antisera against each of the five immunoglobulin classes in order to calculate the percentage of plasma cells positive for these isotypes. Two more slides were stained with TRITC antisera to kappa and lambda light chains, respectively, and counterstained with FITC labelled anti-IgD serum for the calculation of the light chain type distribution within the IgD isotype. At least 50 positive cells were scored in most of the specimens in both the kappa IgD and in the lambda IgD slides. Only in five patients with a low number of IgD containing cells was less than 50 but more than 25 cells per each light chain type counted. Because of insufficient data on the normal frequency of IgD+ bone marrow plasma cells among those of all isotypes, a provisional upper limit was set at 10% on the basis of the mean value plus two standard deviations as determined in a group of 66 adult patients without an overt immune system disease. All conjugated antisera were shown to be specific by performance testing according to Schuit, Moree van der Linde & Hijmans (1981). The slides were evaluated by direct immunofluorescence (IF) with a Zeiss standard microscope equipped for selective visualization of TRITC and FITC. 656 J. A. van Nieuwkoop & J. Radl Antisera used in the different techniques. Goat anti-IgD-FITC (IF): Cappel Laboratories Inc., Downington, Pennsylvania, USA. Sheep anti-IgE-FITC (IF): Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands. Rabbit anti-kappa and anti-lambda light chains (IFIX), rabbit anti-IgM-FITC (IF): Dakopatts, A/S, Copenhagen, Denmark. Sheep anti-fab fragments of IgG and goat anti-IgM (IFIX), rabbit anti-kappa and lambda light chains, and rabbit anti-IgD (IS): TNO Institute for Experimental Gerontology, Rijswijk, The Netherlands. Burro anti-kappa and anti-lambda TRITC and goat anti-kappa FITC (IF): Kallestad Laboratories Inc., Chaska, Minnesota, USA. Rabbit anti-Ig (GAMD, kappa and lambda) (IEP), goat anti-IgG, goat anti-IgA (IFIX), goat anti-IgG-FITC, goat anti-IgA-FITC (IF): Nordic Immunological Laboratories, Tilburg, The Netherlands. Statistics. The Spearman rank order correlation coefficient was used to assess the significance of differences between the percentages of IgD positive plasma cells in the bone marrow and their kappa/lambda ratios. Table 1. Clinical and laboratory features of the individuals investigated IgD in bone marrow IgD in serum Number Sex Age Diagnosist %IgD§ %K-%O) Ratio iu/ml mg/dl 1 F 20 1 81 76-24 3 17 5,300 757 2 F 34 4 43-3 61-39 1 56 383 55 3 F 31 1 36 59-41 1 44 1,383 198 4 M 64 2 33.8 44-56 0-79 240 34 5 M 33 2 28 9 31-69 0 45 NS NS 6 M 18 1 28 77-23 3-35 674 96 7 M 29 4 27-8 30-70 0-43 238 34 8 F 48 3* 20-4 40-60 0-67 188 27 9 F 48 2* 14 5 8-92 0-09 225 32 10 M 43 2 8-9 10-90 0 11 240 34 11 F 41 2 7.8 48-52 0 92 159 23 12 M 53 2* 7-2 28-72 0 39 31 4 13 F 57 3 6-6 9-91 0 10 NS NS 14 M 37 3* 50 13-87 015 40 6 15 M 78 2 4-8 48-52 0-92 < 20 < 3 16 M 80 2 4-7 13-87 0-15 <40 <6 17 F 60 2 4 0 28-72 0 39 NS NS 18 F 68 2* 34 16-84 0.19 61 9 19 F 54 2* 3-2 33-67 0-49 < 20 < 3 20 M 63 2* 3-2 6-94 0-06 44 6 21 M 43 2 30 10-90 011 NS NS 22 F 56 2* 2-9 41-59 0 69 27 4 23 F 67 3 1.9 21-79 0 27 NS NS 24 F 53 3* 1.9 10-90 0 11 28 4 25 M 55 3* 1-4 29-71 0 41 51 7 t See text.
Load more

Recommended publications
  • The Ligands for Human Igg and Their Effector Functions
    antibodies Review The Ligands for Human IgG and Their Effector Functions Steven W. de Taeye 1,2,*, Theo Rispens 1 and Gestur Vidarsson 2 1 Sanquin Research, Dept Immunopathology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] 2 Sanquin Research, Dept Experimental Immunohematology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] * Correspondence: [email protected] Received: 26 March 2019; Accepted: 18 April 2019; Published: 25 April 2019 Abstract: Activation of the humoral immune system is initiated when antibodies recognize an antigen and trigger effector functions through the interaction with Fc engaging molecules. The most abundant immunoglobulin isotype in serum is Immunoglobulin G (IgG), which is involved in many humoral immune responses, strongly interacting with effector molecules. The IgG subclass, allotype, and glycosylation pattern, among other factors, determine the interaction strength of the IgG-Fc domain with these Fc engaging molecules, and thereby the potential strength of their effector potential. The molecules responsible for the effector phase include the classical IgG-Fc receptors (FcγR), the neonatal Fc-receptor (FcRn), the Tripartite motif-containing protein 21 (TRIM21), the first component of the classical complement cascade (C1), and possibly, the Fc-receptor-like receptors (FcRL4/5). Here we provide an overview of the interactions of IgG with effector molecules and discuss how natural variation on the antibody and effector molecule side shapes the biological activities of antibodies. The increasing knowledge on the Fc-mediated effector functions of antibodies drives the development of better therapeutic antibodies for cancer immunotherapy or treatment of autoimmune diseases.
    [Show full text]
  • Mcb 407-Immunology and Immunochemistry-Lecture Note
    MCB 407-IMMUNOLOGY AND IMMUNOCHEMISTRY-LECTURE NOTE DR. D. A. OJO BRIEF HISTORICAL REVIEW OF IMMUNOLOGY The mechanism by which antibody are formed has been debated for years. It was proposed that the specificity of an antibody molecule was determined both by its amino acid sequence but by the molding of the peptide chain around the antigenic determinant. This theory lost favour when it became apparent that antibody-forming cells were devoid of antigen and that antibody specificity was a function of amino acid sequence. At present, the CLONAL (proposed by Burnete) SELECTION THEORY is widely accepted. It holds that an immunologically responsive cell can respond to only one antigen or a closely related group of antigens and that this property is inherent in the cell before the antigen is encountered. According to the clonal selection theory, each individual is endowed with a very large pool of lymphocytes, each of which is capable of responding to a different antigen. When the antigen enters the body, it selects the lymphocyte which has the best “fit” by virtue of a surface receptor. The antigen binds to this antibody-like receptor, and the cell is stimulated to proliferate and form a clone of cells. Thus, selected cells quickly differentiate into plasma cells and secrete antibody which is specific for the antigen which served as the original selecting agent (or a closely related group of antigens). The History of Blood Transfusion Man’s centuries-long desire to perform blood transfusion as a therapeutic procedure forms the cornerstone of the modern science of immunohematology. At present time, the use of whole blood is a well-accepted and commonly employed measure without which many modern surgical procedures could not be carried out.
    [Show full text]
  • B Cell Checkpoints in Autoimmune Rheumatic Diseases
    REVIEWS B cell checkpoints in autoimmune rheumatic diseases Samuel J. S. Rubin1,2,3, Michelle S. Bloom1,2,3 and William H. Robinson1,2,3* Abstract | B cells have important functions in the pathogenesis of autoimmune diseases, including autoimmune rheumatic diseases. In addition to producing autoantibodies, B cells contribute to autoimmunity by serving as professional antigen- presenting cells (APCs), producing cytokines, and through additional mechanisms. B cell activation and effector functions are regulated by immune checkpoints, including both activating and inhibitory checkpoint receptors that contribute to the regulation of B cell tolerance, activation, antigen presentation, T cell help, class switching, antibody production and cytokine production. The various activating checkpoint receptors include B cell activating receptors that engage with cognate receptors on T cells or other cells, as well as Toll-like receptors that can provide dual stimulation to B cells via co- engagement with the B cell receptor. Furthermore, various inhibitory checkpoint receptors, including B cell inhibitory receptors, have important functions in regulating B cell development, activation and effector functions. Therapeutically targeting B cell checkpoints represents a promising strategy for the treatment of a variety of autoimmune rheumatic diseases. Antibody- dependent B cells are multifunctional lymphocytes that contribute that serve as precursors to and thereby give rise to acti- cell- mediated cytotoxicity to the pathogenesis of autoimmune diseases
    [Show full text]
  • The Adaptive Immune Response B-Cells
    The Adaptive Immune Response B-cells The innate immune system provides immediate protection. The adaptive response takes time to develop and is antigen specific. Activation of B and T lymphocytes Naive Plasma cells Naive ADAPTIVE IMMUNITY The adaptive immune system consists of lymphocytes and their products, including antibodies. The receptors of lymphocytes are much more diverse than those of the innate immune system, but lymphocytes are not inherently specific for microbes, and they are capable of recognizing a vast array of foreign substances. http://www.pathologystudent.com/wp- content/uploads/2010/07/normal-lymphs.jpg There are two types of adaptive Immunity Humoral immunity: mediated by B lymphocytes and their secreted products, antibodies (also called immunoglobulins, Ig) that protects against extracellular microbes and their toxins. Cellular immunity: mediated by T lymphocytes and is responsible for defense against intracellular microbes. content/uploads/2011/05/adoptive_immunity.gif - sheng.com/wp - http://yang Types of Adaptive Immune Reponses Lymphocytes Although lymphocytes appear morphologically unimpressive and similar to one another, they are actually remarkably heterogeneous and specialized in molecular properties and functions. Lymphocytes and other cells involved in immune responses are not fixed in particular tissues (as are cells in most of the organs of the body) but are capable of migrating among lymphoid and other tissues and the vascular and lymphatic circulations. This feature permits lymphocytes to home to any site of infection. In lymphoid organs, different classes of lymphocytes are anatomically segregated in such a way that they interact with one another only when stimulated to do so by encounter with antigens and other stimuli.
    [Show full text]
  • Structural Features of Human Immunoglobulin G That Determine Isotype-Specitic Differences in Complement Activation by Mi-Hua Tao,* Richard I.F
    Structural Features of Human Immunoglobulin G that Determine Isotype-specitic Differences in Complement Activation By Mi-Hua Tao,* Richard I.F. Smith,* and Sherie L. Morrison*r From the "Department of Microbiology and Molecular Genetics and IThe Molecular Biology Institute, University of California, Los Angeles, California 90024 Summary Although very similar in sequence, the four subclasses of human immunoglobulin G (IgG) differ markedly in their ability to activate complement. Glu318-Lys320-Lys322 has been identified as Downloaded from http://rupress.org/jem/article-pdf/178/2/661/1268014/661.pdf by guest on 30 September 2021 a key binding motif for the first component of complement, Clq, and is present in all isotypes of Ig capable of activating complement. This motif, however, is present in all subclasses of human IgG, including those that show little (IgG2) or even no (IgG4) complement activity. Using point mutants of chimeric antibodies, we have identified specificresidues responsible for the differing ability of the IgG subclasses to fix complement. In particular, we show that Ser at position 331 in 3/4 is critical for determining the inability of that isotype to bind Clq and activate complement. Additionally, we provide further evidence that levels of Clq binding do not necessarily correlate with levels of complement activity, and that Clq binding alone is not sufficient for complement activation. he classical pathway of complement activation is initi- tivation ability and an IgG4 with the hinge of IgG3, although T ated by immune complexes composed of antigen and ei- as flexible as wild-type IgG3, displays no detectable comple- ther IgM or IgG Abs.
    [Show full text]
  • Nasopharyngeal Infection by Streptococcus Pyogenes Requires Superantigen-Responsive Vβ-Specific T Cells
    Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells Joseph J. Zeppaa, Katherine J. Kaspera, Ivor Mohorovica, Delfina M. Mazzucaa, S. M. Mansour Haeryfara,b,c,d, and John K. McCormicka,c,d,1 aDepartment of Microbiology and Immunology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada; bDepartment of Medicine, Division of Clinical Immunology & Allergy, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5A5, Canada; cCentre for Human Immunology, Western University, London, ON N6A 5C1, Canada; and dLawson Health Research Institute, London, ON N6C 2R5, Canada Edited by Philippa Marrack, Howard Hughes Medical Institute, National Jewish Health, Denver, CO, and approved July 14, 2017 (received for review January 18, 2017) The globally prominent pathogen Streptococcus pyogenes secretes context of invasive streptococcal disease is extremely dangerous, potent immunomodulatory proteins known as superantigens with a mortality rate of over 30% (10). (SAgs), which engage lateral surfaces of major histocompatibility The role of SAgs in severe human infections has been well class II molecules and T-cell receptor (TCR) β-chain variable domains established (5, 11, 12), and specific MHC-II haplotypes are known (Vβs). These interactions result in the activation of numerous Vβ- risk factors for the development of invasive streptococcal disease specific T cells, which is the defining activity of a SAg. Although (13), an outcome that has been directly linked to SAgs (14, 15). streptococcal SAgs are known virulence factors in scarlet fever However, how these exotoxins contribute to superficial disease and and toxic shock syndrome, mechanisms by how SAgs contribute colonization is less clear.
    [Show full text]
  • A Challenging Case of Igd Kappa Multiple Myeloma Associated with Primary Amyloidosis: Importance of Serum Free Light Chains in M
    L al of euk rn em u i o a J Journal of Leukemia García de Veas Silva JL et al, J Leuk 2014, 2:5 ISSN: 2329-6917 DOI: 10.4172/2329-6917.1000164 Case Report Open Access A Challenging Case of IgD Kappa Multiple Myeloma Associated With Primary Amyloidosis: Importance of Serum Free Light Chains in Monitoring Treatment Response and Disease Relapse José Luis García de Veas Silva1*, Carmen Bermudo Guitarte1, Paloma Menéndez Valladares1, Rafael Duro Millán2 and Johanna Carolina Rojas Noboa2 1Department of Clinical Biochemistry, Hospital Universitario Virgen Macarena, Sevilla, Spain 2Department of Hematology, Hospital Universitario Virgen Macarena, Sevilla, Spain *Corresponding author: José Luis García de Veas Silva, Laboratory of Proteins, Department of Clinical Biochemistry, Hospital Universitario Virgen Macarena, Sevilla, Spain, Tel: +034955008108; E-mail: [email protected] Rec date: Oct 10, 2014, Acc date: Oct 16, 2014; Pub date: Oct 24, 2014 Copyright: © 2014 García de Veas Silva JL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Multiple Myeloma (MM) is a malignancy of B cells characterized by an atypical proliferation of plasma cells. IgD MM has a very low incidence (2% of total MM cases) and it´s characterized by an aggressive course and a worse prognosis than other subtypes. The serum free light chains (sFLC) are very important markers for monitoring patients with MM and other monoclonal gammopathies. When the sFLC are present in low concentrations, it is often difficult to detect them by conventional methods such as serum protein electrophoresis and serum immunofixation.
    [Show full text]
  • Clinically-Relevant Monoclonal Antibodies
    ANTIBODIES ISOTYPE FAMILIES Switch natural isotypes Clinically relevant monoclonal antibodies Fine-tuned effector functions Up to 14 different native and engineered isotypes InvivoGen provides a series of clinically relevant antibodies in their original Antibodies against format or with different immunoglobulin isotypes. Our engineered antibodies various targets are designed to adjust their effector functions, including half-life, complement- Anti-hCD20 Anti-hPD1 dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity Anti-hCTLA4 Anti-hPD-L1 (ADCC) and antibody-dependent cell phagocytosis (ADCP). The variety of Anti-hEGFR Anti-hTNF-α the immunoglobulin constant regions helps you determine the most suitable Anti-HER2 Anti-hVEGF isotype for your application. WWW.INVIVOGEN.COM/ANTIBODY-ISOTYPES Description Monoclonal antibodies (mAbs) have become a major tool in the treatment of cancer and auto-immune diseases. The efficacy of antibodies is governed by their bifunctional nature. On the one hand, the variable domain of the immunoglobulin, within the fragment of antigen binding (Fab), confers antigen specificity function. On the other hand, the fragment crystallizable region (Fc) in the constant domain of the immunoglobulin triggers antibody-mediated effector functions by engaging a variety of Fc receptors. Antibody isotype switching is a biological process enabling changes in the ability of the antibody to interact with different Fc receptors and thus, reduce or potentiate effector functions. InvivoGen’s antibody isotype families consist of clinically relevant mAbs comprising the same variable domain and the constant domain of various isotypes, therefore differing in their suitability for a given application. Native and engineered isotypes Features of our antibody isotype families • Native isotype antibodies Physiological native isotypes trigger various combinations of Specificities Fragment antigen effector functions that are summarized in the table below.
    [Show full text]
  • The Importance of Using an Isotype Control
    The Importance of Using an Isotype Control White Paper What are Isotype Controls? Isotype control antibodies are essential negative controls for in vivo studies and can play an important role in standard immunoassays, such as flow cytometry and immunohistochemistry (IHC). They match the characteristics of the assay’s primary antibody (e.g. isotype, clonality), but having been raised against antigens known not to be present in common preclinical species (HEL, KLH, etc.), have no target cell/antigen specificity. This provides researchers with a suitable negative control to accurately discriminate between an antibody binding in an antigen-dependent specific manner from non-antigen dependent mAb binding due to Fc receptors (FcR) or other proteins. In the simplest terms, isotype controls help distinguish non- specific background signal from specific antibody signal. Monoclonal, subclass specific (i.e. lambda vs. kappa immunoglobulin) isotype controls provide an especially reliable method that effectively differentiates between specificity versus background in a range of drug development assays. Why is it Important to Use Isotype Controls? Structurally, all antibodies are very similar, with only a small hypervariable region determining antigen specific binding. The rest of the antibody molecule consists of Using an the constant region, where sequences are often shared by antibodies of the same “appropriate isotype. isotype control allows the true The constant regions help determine antibody mechanism of action, by coordinating determination binding to the FcR present on many cell types. FcRs are expressed on a number of different cell types in the immune system, including (but not limited to): of specific vs non-antigen • B lymphocytes specific • follicular dendritic cells binding • natural killer cells across a range • macrophages • neutrophils of in vivo “ studies and • eosinophils Immunoassays • basophils • human platelets • mast cells.
    [Show full text]
  • Igd Class Switch Recombination Is Not Controlled Through the Immunoglobulin Heavy Chain 3&Prime
    Cellular & Molecular Immunology (2017) 14, 871–874 & 2017 CSI and USTC All rights reserved 2042-0226/17 $32.00 www.nature.com/cmi LETTER TO THE EDITOR IgD class switch recombination is not controlled through the immunoglobulin heavy chain 3′ regulatory region super-enhancer Hussein Issaoui1, Nour Ghazzaui1, Alexis Saintamand2, Yves Denizot and François Boyer Cellular & Molecular Immunology (2017) 14, 871–874; doi:10.1038/cmi.2017.81; published online 4 September 2017 n secondary lymphoid organs, mature enigmatic event restricted to a few B-cell 3’RR-deficient mouse B cells were used IB cells express membrane immuno- subsets in specific lymphoid tissues (such for these experiments. In some experi- globulin (Ig) of M and D isotypes (IgM as mesenteric lymph nodes, peritoneal ments, 3′RR-deficient mice were and IgD, respectively) of the same spe- cavity and mucosa-associated tissue) in pristane-treated (1 ml) for 2 months to cificity through alternative splicing of a both mice and humans.3–5 A recent induce inflammation prior to the recov- pre-mRNA encompassing the VDJ vari- study suggested that IgD CSR is initiated ery of peritoneal cavity cells. As pre- 5 4 able region and Cμ and Cδ heavy chain by microbiota, demonstrating a role for viously described in detail, junctions constant exons.1 After encountering anti- IgD in the homeostatic regulation of the were amplified using touchdown PCR gen, B cells undergo class switch recom- microbial community. The mechanistic followed by nested PCR. Libraries of bination (CSR) by which the Cμ gene is regulation of IgD CSR remains enig- 200 bp were prepared from the 1–2kb substituted with Cγ, Cε or Cα, thereby matic, reflecting the difficulty to obtain PCR products of Sμ–σδ amplification for generating IgG, IgE and IgA antibodies asufficient number of Sμ–σδ (σ for ion proton sequencing (‘GénoLim plat- of the same antigenic specificity but with S-like) junction sequences for molecular form’ of the Limoges University, France).
    [Show full text]
  • A Novel Superantigen Isolated from Pathogenic Strains of Streptococcus Pyogenes with Aminoterminal Homology to Staphylococcal Enterotoxins B and C
    A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J A Mollick, … , D Grossman, R R Rich J Clin Invest. 1993;92(2):710-719. https://doi.org/10.1172/JCI116641. Research Article Streptococcus pyogenes (group A Streptococcus) has re-emerged in recent years as a cause of severe human disease. Because extracellular products are involved in streptococcal pathogenesis, we explored the possibility that a disease isolate expresses an uncharacterized superantigen. We screened culture supernatants for superantigen activity with a major histocompatibility complex class II-dependent T cell proliferation assay. Initial fractionation with red dye A chromatography indicated production of a class II-dependent T cell mitogen by a toxic shock-like syndrome (TSLS) strain. The amino terminus of the purified streptococcal superantigen was more homologous to the amino termini of staphylococcal enterotoxins B, C1, and C3 (SEB, SEC1, and SEC3), than to those of pyrogenic exotoxins A, B, C or other streptococcal toxins. The molecule, designated SSA, had the same pattern of class II isotype usage as SEB in T cell proliferation assays. However, it differed in its pattern of human T cell activation, as measured by quantitative polymerase chain reaction with V beta-specific primers. SSA activated human T cells that express V beta 1, 3, 15 with a minor increase of V beta 5.2-bearing cells, whereas SEB activated V beta 3, 12, 15, and 17-bearing T cells. Immunoblot analysis of 75 disease isolates from several localities detected SSA production only in group A streptococci, and found that SSA is apparently confined to only three clonal […] Find the latest version: https://jci.me/116641/pdf A Novel Superantigen Isolated from Pathogenic Strains of Streptococcus pyogenes with Aminoterminal Homology to Staphylococcal Enterotoxins B and C Joseph A.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]